Healthcare Industry News: Magnetic Resonance Imaging
News Release - April 4, 2007
Revolutions Medical Corp (RMCP) Announces Completion of Clear Image Acquisition And Launches New WebsiteMOUNT PLEASANT, S.C.--(HSMN NewsFeed)--Revolutions Medical Corp (OTC: RMCP ) announces the completion of Clear Image Acquisition and launches its new website at www.revolutionsmedical.com. The new website has two videos; one is for the Rev Vac 3cc safety syringe and the other describes the new acquisition. Now investors can review Revolution Medical Corp's products and intellectual properties and get up to date information on the company, including stock price, press releases, and SEC filings.
"I am very pleased to have accomplished such a monumental acquisition for Revolutions Medical shareholders," states Ron Wheet, CEO Revolutions Medical Corp. "The proprietary MRI software tools that Rev Med now owns; color, 3D, and auto segmentation, addresses such a huge market that continues to have double-digit growth. The need for quicker, reliable patient diagnosis is a must for the health care industry. I feel Rev Med's new MRI proprietary technology will assist with these important health care needs and will continue to develop new products for the medical industry."
In 2003, an estimated 21 million MRI procedures were performed. That's a jump of 22% from the 18 million procedures performed in 2001, according to estimates from the IMV Ltd's Medical Information Division, an international organization that analyzes science-based instrument industries. Looking ahead, the installed base is predicted to grow about 35-40% over the next 5 years. Approximately 9,500 units are expected to be installed by 2008-2009. With the development of open systems, Magnetic Resonance Imaging (MRI) has evolved into the best imaging procedure for many organs and structures, including brain, spine, bones, and joints, leading MRI equipment to become a 3.5 billion world wide industry today. According to a Kalorama Information study, "Medical Imaging Markets Volume II," Magnetic Resonance in the global market will continue to grow with anticipated revenues topping USD 4 billion in 2010.
About Revolutions Medical Corporation
Revolutions Medical Corporation is committed to continually developing and distributing new products and tools to the medical industry, whether internally or through acquisitions. Its goals are to make health care safer and less expensive by reducing risks and cutting time and expenses. Its products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.
Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.
Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.
Source: Revolutions Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.